Suspend circulation of Celetop 200 medicine for gout treatment
The Drug Administration of Vietnam has just requested to suspend the nationwide circulation of Celetop 200 (Celecoxib 200mg) capsules due to not meeting quality standards regarding solubility.
Illustration photo. (Source: vnp.com)
Celetop 200 is used to treat rheumatoid arthritis, osteoarthritis, gout and other bone and joint diseases.
According to Deputy Director of the Drug Administration of Vietnam Nguyen Viet Hung, the drug Celetop 200, which has been suspended from circulation, has registration number VN-6401-08 and is manufactured by Amtec Health Care Pvt. Ltd. (India).
Celetop 200 capsules have been suspended from circulation nationwide, production batch: 11042; expiry date: October 15, 2014. The drug is imported by Ho Chi Minh City Medical Import-Export Joint Stock Company.
The Ho Chi Minh City Drug Testing Institute took drug samples for quality testing at the branch of Eco Pharmaceutical Joint Stock Company (Hanoi) in Ho Chi Minh City and the results showed that they did not meet quality standards regarding solubility.
The Drug Administration of Vietnam requested Ho Chi Minh City Medical Import-Export Joint Stock Company to send a recall notice to places distributing and using Celetop 200 capsules.
Provincial and municipal health departments need to notify drug businesses and users to recall the above substandard batch of drugs.
In addition, the above units need to inspect and supervise the units implementing the recall and strictly handle violations./.
According to (Vietnam+) - NT
